PAVM Insider Trading Activity and SEC Form 4 Filings
PAVM insider trading summary
No open-market insider purchases or sales of PAVmed Inc. (PAVM) have been reported on SEC Form 4 in the past 12 months.
Latest PAVM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 7, 2022 | Michael J Glennon | Director | Buy | $62K (100,000 @ $0.62) |
| Dec 6, 2022 | Michael J Glennon | Director | Buy | $56K (88,000 @ $0.64) |
| Dec 5, 2022 | Michael J Glennon | Director | Buy | $43K (62,000 @ $0.69) |
| Mar 18, 2021 | Lishan Aklog | Chairman and CEO | Buy | $32K (7,500 @ $4.31) |
| Mar 18, 2021 | Pavilion Venture Partners LLC | 10% Owner | Buy | $32K (7,500 @ $4.31) |
| Nov 25, 2020 | Matthew Sirovich | 10% Owner | Sell | $65K (33,203 @ $1.96) |
| Nov 24, 2020 | Matthew Sirovich | 10% Owner | Sell | $106K (53,036 @ $2.00) |
| Nov 19, 2020 | Matthew Sirovich | 10% Owner | Sell | $137K (75,211 @ $1.83) |
| Nov 18, 2020 | Matthew Sirovich | 10% Owner | Sell | $44K (24,789 @ $1.78) |
| May 29, 2020 | Matthew Sirovich | 10% Owner | Sell | $259K (131,082 @ $1.98) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.